MRI of malignant neoplasms of the uterine corpus and cervix

American Journal of Roentgenology

Volumn 188, Issue 6, 2007, Pages 1577-1587

  Sala, Evis ^a   Wakely, Suzanne ^a   Senior, Emma ^a   Lomas, David ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dynamic MRI; Genitourinary tract imaging; Gynecologic oncology; MRI; Oncologic imaging; Women's imaging

Indexed keywords

AGED; CANCER DIAGNOSIS; CANCER STAGING; DIAGNOSTIC IMAGING; ENDOMETRIUM CARCINOMA; ENDOMETRIUM SARCOMA; FEMALE; FOLLOW UP; HUMAN; LEIOMYOSARCOMA; LYMPH NODE; MIXED MULLERIAN TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; TUMOR RECURRENCE; UTERINE CERVIX CANCER; UTERUS CANCER; UTERUS SARCOMA;

CERVIX UTERI; FEMALE; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; UTERINE CERVICAL NEOPLASMS; UTERINE NEOPLASMS; UTERUS;

EID: 34249868742     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.06.1196     Document Type: Review

References (75)

1. Hricak H, Mendelson E, Bohm-Velez M, et al. Role of imaging in cancer of the cervix. American College of Radiology. ACR appropriateness criteria. Radiology 2000; 215[suppl]:925-930
2. Hricak H, Mendelson E, Bohm-Velez M, et al. Endometrial cancer of the uterus. American College of Radiology. ACR appropriateness criteria. Radiology 2000; 215[suppl]:947-953
3. Kinkel K, Ariche M, Tardivon AA, et al. Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging. Radiology 1997; 204:55-63
4. Scheidler J, Hricak H, Yu KK, Subak L, Segal MR. Radiological evaluation of lymph node metastases in patients with cervical cancer: a meta-analysis. JAMA 1997; 278:1096-1101
5. Rockall AG, Sohaib SA, Harisinghani MG, et al. Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer. J Clin Oncol 2005; 23:2813-2821
6. Heller D, Hricak H. Cost-effectiveness of new technologies for staging endometrial cancer. Eur Radiol 2000; 10[suppl3]:S381-S385
7. Hricak H, Powell CB, Yu KK, et al. Invasive cervical carcinoma: role of MR imaging in pretreatment work-up - cost minimization and diagnostic efficacy analysis. Radiology 1996; 198:403-409
8. Rha SE, Byun JY, Jung SE, et al. CT and MRI of uterine sarcomas and their mimickers. AJR 2003; 181:1369-1374
9. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2007. CA Cancer J Clin 2007; 57:43-66
10. Larson DM, Connor GP, Broste SK, Krawisz BR, Johnson KK. Prognostic significance of gross myometrial invasion with endometrial cancer. Obstet Gynecol 1996; 88:394-398
11. Frei KA, Kinkel K, Bonel HM, Lu Y, Zaloudek C, Hricak H. Prediction of deep myometrial invasion in patients with endometrial cancer: clinical utility of contrast-enhanced MR imaging - a meta-analysis and Bayesian analysis. Radiology 2000; 216:444-449
12. Shibutani O, Joja I, Shiraiwa M, et al. Endometrial carcinoma: efficacy of thin-section oblique axial MR images for evaluating cervical invasion. Abdom Imaging 1999; 24:520-526
13. Yamashita Y, Harada M, Sawada T, Takahashi M, Miyazaki K, Okamura H. Normal uterus and FIGO stage I endometrial carcinoma: dynamic gadolinium-enhanced MR imaging. Radiology 1993; 186:495-501
14. Manfredi R, Mirk P, Maresca G, et al. Local-regional staging of endometrial carcinoma: role of MR imaging in surgical planning. Radiology 2004; 231:372-378
15. Ascher SM, Reinhold C. Imaging of cancer of the endometrium. Radiol Clin North Am 2002; 40:563-576
16. Eltabbakh GH, Shamonki MI, Moody JM, Garafano LL. Laparoscopy as the primary modality for the treatment of women with endometrial carcinoma. Cancer 2001; 91:378-387
17. Wong CK, Wong YH, Lo LS, Tai CM, Ng TK. Laparoscopy compared with laparotomy for the surgical staging of endometrial carcinoma. J Obstet Gynaecol Res 2005; 31:286-290
18. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980; 136:679-688
19. Boronow RC, Morrow CP, Creasman WT, et al. Surgical staging in endometrial cancer: clinical-pathologic findings of a prospective study. Obstet Gynecol 1984; 63:825-832
20. Piver MS, Lele SB, Barlow JJ, Blumenson L. Paraaortic lymph node evaluation in stage I endometrial carcinoma. Obstet Gynecol 1982; 59:97-100
21. Sironi S, De Cobelli F, Scarfone G, et al. Carcinoma of the cervix: value of plain and gadolinium-enhanced MR imaging in assessing degree of invasiveness. Radiology 1993; 188:797-801
22. Goff BA, Rice LW. Assessment of depth of myometrial invasion in endometrial adenocarcinoma. Gynecol Oncol 1990; 38:46-48
23. Quinlivan JA, Petersen RW, Nicklin JL. Accuracy of frozen section for the operative management of endometrial cancer. BJOG 2001; 108:798-803
24. Creutzberg CL. Lymphadenectomy in apparent early-stage endometrial carcinoma: do numbers count? J Clin Oncol 2005; 23:3653-3655
25. Maggino T, Romagnolo C, Landoni F, Sartori E, Zola P, Gadducci A. An analysis of approaches to the management of endometrial cancer in North America: a CTF study. Gynecol Oncol 1998; 68:274-279
26. Barwick TD, Rockall AG, Barton DP, Sohaib SA. Imaging of endometrial adenocarcinoma. Clin Radiol 2006; 61:545-555
27. Ito K, Matsumoto T, Nakada T, Nakanishi T, Fujita N, Yamashita H. Assessing myometrial invasion by endometrial carcinoma with dynamic MRI. J Comput Assist Tomogr 1994; 18:77-86
28. Joja I, Asakawa M, Asakawa T, et al. Endometrial carcinoma: dynamic MRI with turbo-FLASH technique. J Comput Assist Tomogr 1996; 20:878-887
29. Seki H, Kimura M, Sakai K. Myometrial invasion of endometrial carcinoma: assessment with dynamic MR and contrast-enhanced T1-weighted images. Clin Radiol 1997; 52:18-23
30. Kim SH, Kim HD, Song YS, Kang SB, Lee HP. Detection of deep myometrial invasion in endometrial carcinoma: comparison of transvaginal ultrasound, CT, and MR1. J Comput Assist Tomogr 1995; 19:766-772
31. Kinkel K, Kaji Y, Yu KK, et al. Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology 1999; 212:711-718
32. Hricak H, Stern JL, Fisher MR, Shapeero LG, Winkler ML, Lacey CG. Endometrial carcinoma staging by MR imaging. Radiology 1987; 162:297-305
33. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaging evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991;179:829-832
34. Sironi S, Colombo E, Villa G, et al. Myometrial invasion by endometrial carcinoma: assessment with plain and gadolinium-enhanced MR imaging. Radiology 1992; 185:207-212
35. Scoutt LM, McCarthy SM, Flynn SD, et al. Clinical stage I endometrial carcinoma: pitfalls in preoperative assessment with MR imaging - work in progress. Radiology 1995; 194:567-572
36. Lee EJ, Byun JY, Kim BS, Koong SE, Shinn KS. Staging of early endometrial carcinoma: assessment with T2-weighted and gadolinium-enhanced T1-weighted MR imaging. RadioGraphics 1999; 19:937-945
37. Lien HH, Blomlie V, Trope C, Kaern J, Abeler VM. Cancer of the endometrium: value of MR imaging in determining depth of invasion into the myometrium. AJR 1991; 157:1221-1223
38. Yamashita Y, Mizutani H, Torashima M, et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR 1993; 161:595-599
39. Seki H, Takano T, Sakai K. Value of dynamic MR imaging in assessing endometrial carcinoma involvement of the cervix. AJR 2000; 175:171-176
40. Low RN, Duggan B, Barone RM, Saleh F, Song SY. Treated ovarian cancer: MR imaging, laparotomy reassessment, and serum CA-125 values compared with clinical outcome at 1 year. Radiology 2005; 235:918-926
41. Sahdev A, Sohaib SA, Jacobs I, Shepherd JH, Oram DH, Reznek RH. MR imaging of uterine sarcomas. AJR 2001; 177:1307-1311
42. Shapeero LG, Hricak H. Mixed müllerian sarcoma of the uterus: MR imaging findings. AJR 1989; 153:317-319
43. Pattani SJ, Kier R, Deal R, Luchansky E. MRI of uterine leiomyosarcoma. Magn Reson Imaging 1995; 13:331-333
44. Okamoto Y, Tanaka YO, Nishida M, Tsunoda H, Yoshikawa H, Itai Y. MR imaging of the uterine cervix: imaging-pathologic correlation. RadioGraphics 2003; 23:425-445
45. Hawighorst H, Schoenberg SO, Knapstein PG, et al. Staging of invasive cervical carcinoma and of pelvic lymph nodes by high resolution MRI with a phased-array coil in comparison with pathological findings. J Comput Assist Tomogr 1998; 22:75-81
46. Yu KK, Hricak H, Subak LL, Zaloudek CJ, Powell CB. Preoperative staging of cervical carcinoma: phased array coil fast spin-echo versus body coil spin-echo T2-weighted MR imaging. AJR 1998; 171:707-711
47. Shiraiwa M, Joja I, Asakawa T, et al. Cervical carcinoma: efficacy of thin-section oblique axial T2-weighted images for evaluating parametrial invasion. Abdom Imaging 1999; 24:514-519
48. Van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Fast dynamic contrast enhanced MR imaging of cervical carcinoma. Clin Radiol 1998; 53:183-192
49. Scheidler J, Heuck AF, Steinborn M, Kimmig R, Reiser MF. Parametrial invasion in cervical carcinoma: evaluation of detection at MR imaging with fat suppression. Radiology 1998; 206:125-129
50. Lagasse LD, Creasman WT, Shingleton HM, Ford JH, Blessing JA. Results and complications of operative staging in cervical cancer experience of the Gynecologic Oncology Group. Gynecol Oncol 1980; 9:90-98
51. Van Nagell JR Jr, Roddick JW Jr, Lowin DM. The staging of cervical cancer: inevitable discrepancies between clinical staging and pathologic findings. Am J Obstet Gynecol 1971; 110:973-978
52. Creasman WT. New gynecologic cancer staging. Gynecol Oncol 1995; 58:157-158
53. Piver MS, Chung WS. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 1975; 46:507-510
54. Scheidler J, Heuck AF. Imaging of cancer of the cervix. Radiol Clin North Am 2002; 40:577-590
55. Nicolet V, Carignan L, Bourdon F, Prosmanne O. MR imaging of cervical carcinoma: a practical staging approach. RadioGraphics 2000; 20:1539-1549
56. Kaur H, Silverman PM, Iyer RB, Verschraegen CF, Eifel PJ, Charnsangavej C. Diagnosis, staging, and surveillance of cervical carcinoma. AJR 2003; 180:1621-1631
57. Subak LL, Hricak H, Powell CB, Azizi L, Stern JL. Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol 1995; 86:43-50
58. Togashi K, Nishimura K, Itoh K, et al. Uterine cervical cancer: assessment with high-field MR imaging. Radiology 1986; 160:431-435
59. Hricak H, Lacey CG, Sandles LG, Chang YC, Winkler ML, Stern JL. Invasive cervical carcinoma: comparison of MR imaging and surgical findings. Radiology 1988; 166:623-631
60. Seki H, Azumi R, Kimura M, Sakai K. Stromal invasion by carcinoma of the cervix: assessment with dynamic MR imaging. AJR 1997; 168:1579-1585
61. Yamashita Y, Takahashi M, Sawada T, Miyazaki K, Okamura H. Carcinoma of the cervix: dynamic MR imaging. Radiology 1992; 182:643-648
62. Kim SH, Choi BI, Han JK, et al. Preoperative staging of uterine cervical carcinoma: comparison of CT and MR1 in 99 patients. J Comput Assist Tomogr 1993; 17:633-640
63. Kim SH, Choi BI, Lee HP, et al. Uterine cervical carcinoma: comparison of CT and MR findings. Radiology 1990; 175:45-51
64. Bipat S, Glas AS, van der Velden J, Zwinderman AH, Bossuyt PM, Stoker J. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 2003; 91:59-66
65. Sheu M, Chang C, Wang J, Yen M. MR staging of clinical stage I and IIa cervical carcinoma: a reappraisal of efficacy and pitfalls. Eur J Radiol 2001; 38:225-231
66. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183. J Clin Oncol 2005; 23:9329-9337
67. Peppercorn PD, Jeyarajah AR, Woolas R, et al. Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience. Radiology 1999; 212:395-399
68. Rockall AG, Ghosh S, Alexander-Sefrc F, et al. Can MR1 rule out bladder und rectal invasion in cervical cancer to help select patients for limited EUA? Gynecol Oncol 2006; 101:244-249
69. Inoue T, Monta K. The prognostic significance of number of positive nodes in cervical carcinoma stages IB, IIA, and IIB. Cancer 1990; 65:1923-1927
70. Williams AD, Cousins C, Soutter WP, et al. Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography. AJR 2001; 177:343-348
71. Yang WT, Lam WW, Yu MY, Cheung TH, Metreweli C. Comparison of dynamic helical CT and dynamic MR imaging in the evaluation of pelvic lymph nodes in cervical carcinoma. AJR 2000; 175:759-766
72. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 2006; 238:272-279
73. Xue F, Lin LL, Dehdashti F, Miller TR, Siegel BA, Grigsby PW. F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy. Gynecol Oncol 2006; 101:147-151
74. Fulcher AS, O'Sullivan SG, Segreti EM, Kavanagh BD. Recurrent cervical carcinoma: typical and atypical manifestations. RadioGraphics 1999; 19(Spec No):S103-S116
75. Jeong YY, Kang HK, Chung TW, Seo JJ, Park JG. Uterine cervical carcinoma after therapy: CT and MR imaging findings. RadioGraphics 2003; 23:969-981